Asymmetric bioreduction of an ()-β-cyano-2,4-dienoic acid derivative by ene-reductases allowed a shortened access to a precursor of pregabalin [()-3-(aminomethyl)-5-methylhexanoic acid] possessing the desired configuration in up to 94% conversion and >99% . Deuterium labelling studies showed that the nitrile moiety was the preferred activating/anchor group in the active site of the enzyme over the carboxylic acid or the corresponding methyl ester.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498475 | PMC |
http://dx.doi.org/10.1002/adsc.201301055 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!